2017 was a very successful year, we look back at the highlights and look forward to 2018.
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

13x13x1 READ MORE
Special Report - Is ABcann Canada's Strongest Grower? 
Dear Seed Investor, 

2017 was a major year for Marijuana Stocks, and 2018 is shaping up to be even bigger.  

It's been a year of meteoric growth for multiple Cannabis stocks, with the Cannabis Stock Index up 91% YTD. 

Looking forward to 2018, California, the largest market in the US, is preparing for recreational legalization in January 2018.

Canada is scheduled for full recreational legalization in July 2018, with multiple Canadian provinces already outlining their plans for legalization.

Mergers and acquisitions like the deal between Constellation Brands and Canopy have solidified and legitimized the space. 

This all contributes to an overall bullish outlook heading into 2018.

Here are just a few of the hightlights from 2017:

Canopy Growth Corporation (TSX: WEED) (OTCQB: TWMJF) announced a major deal with with the leading total beverage alcohol supplier in the United States, Constellation Brands (NYSE: STZ and STZ.B).

This deal sees Constellation invest $245 Million in Canopy for ~10% of the company, in a deal that is seen as a "potential game changer for rallying pot stocks" and marks the first major investment in the marijuana space by big alcohol.  

Canopy is the largest cannabis company in the world, and their stock has risen by 367% this year! 

Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) announced a takeover bid to purchase all of the issued and outstanding common shares of CanniMed Therapeutics Inc. (TSX: CMED) (OTCQB: CMMDF).

Although the takeover has not been approved yet and is still being decided in the courts, this was a major story in 2017.

Aurora has seen stock growth of ~373% this year! 

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) is seeing a gain of ~70% over the past 3 months, including a year high of $1.81 for a ~126% gain this year

They solidified their funding with a major deal with Cannabis Wheaton, continued with their robust expansion plans and brought on expertise with the addition of Barry Fishman as CEO.

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) also had a monster year, showing gains of ~160% in the last 3 months alone, and over ~563% year over year! 

They increased shareholder value on the strength of groundbreaking research on their proprietary Biosynthesis program.  This culminated with the recent news of being added to the Horizons Marijuana Life Sciences Index ETF on December 15, 2017

MedReleaf Corp. (TSX:LEAF) (OTCQB: MEDFF) announced that it entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart, Canada's largest retail pharmacy chain, pending Health Canada's approval of Shoppers Drug Mart's application to be a licensed producer.

MedReleaf has seen a ~206% gain this year on the strength of this news. 

All in all it's been a very successful year for Marijuana stocks in general, including our top stock picks. 

Enjoy the rest of your holidays and we look forward to High‘er Profits for the New Year.

High Profits, 

​The Seed Investor
High Profits
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to ABcann Global (ticker symbol TSXV: ABCN / OTCBB: ABCCF will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in TSXV: ABCN / OTCBB: ABCCF and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor.

32x32x1   32x32x2  
9375 E Shea Blvd Ste 100
Scottsdale 85260
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.